SOUTH SAN FRANCISCO, Calif., Aug. 14, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced financial results for the three and six months ended June 30, 2009.
